Atlas Trials

Stage II Prostate Adenocarcinoma

7 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Stage II Prostate Adenocarcinoma

RecordFirmDate
Bicalutamide and Raloxifene Hydrochloride in Treating Patients With Prostate Cancer Undergoing Surgery (NCT03147196)Mayo Clinic2017-06-27
Androgen Receptor Antagonist ARN-509 With or Without Abiraterone Acetate, Gonadotropin-Releasing Hormone Analog, and Prednisone in Treating Patients With High-Risk Prostate Cancer Undergoing Surgery (NCT02949284)Rutgers, The State University of New Jersey2017-06-20
68Ga-RM2 PET/CT in Detecting Regional Nodal and Distant Metastases in Patients With Intermediate or High-Risk Prostate Cancer (NCT03113617)Andrei Iagaru2017-04-10
68Ga-PSMA-11 PET/MRI in Finding Tumors in Patients With Intermediate or High-Risk Prostate Cancer Undergoing Surgery (NCT02678351)Andrei Iagaru2016-04-18
Stereotactic Body Radiation Therapy With Boost Using Urethral-Sparing Intensity-Modulated Radiation Therapy Planning in Treating Patients With Prostate Cancer (NCT02470897)University of Wisconsin, Madison2015-07-24
PLX3397, Radiation Therapy, and Antihormone Therapy in Treating Patients With Intermediate- or High-Risk Prostate Cancer (NCT02472275)Barbara Ann Karmanos Cancer Institute2015-06-01
Hypofractionated Stereotactic Body Radiation Therapy for Patients With Prostate Cancer That Was Removed by Surgery (NCT02446366)University of Southern California2015-05-12

Track Stage II Prostate Adenocarcinoma automatically

Every clearance here is in the API, with alerts when new ones post.